These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9734561)

  • 1. Provocation of a posttraumatic flashback by cholecystokinin tetrapeptide?
    Kellner M; Levengood R; Yehuda R; Wiedemann K
    Am J Psychiatry; 1998 Sep; 155(9):1299. PubMed ID: 9734561
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
    Kellner M; Wiedemann K; Yassouridis A; Levengood R; Guo LS; Holsboer F; Yehuda R
    Biol Psychiatry; 2000 Jan; 47(2):107-11. PubMed ID: 10664826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings.
    Bradwejn J; Koszycki D; Payeur R; Bourin M; Borthwick H
    Am J Psychiatry; 1992 Jul; 149(7):962-4. PubMed ID: 1609879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide.
    Le Melledo JM; Bradwejn J; Koszycki D; Bichet D
    Arch Gen Psychiatry; 1995 Jul; 52(7):605-6. PubMed ID: 7598637
    [No Abstract]   [Full Text] [Related]  

  • 5. Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.
    Koszycki D; Cox BJ; Bradwejn J
    Am J Psychiatry; 1993 Dec; 150(12):1881-3. PubMed ID: 8238648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms.
    Le Mellédo JM; Bradwejn J; Koszycki D; Bichet DG; Bellavance F
    Biol Psychiatry; 1998 Sep; 44(5):364-6. PubMed ID: 9755359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients.
    Bradwejn J; Koszycki D
    Am J Psychiatry; 1994 Feb; 151(2):261-3. PubMed ID: 8296900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sodium lactate-induced panic symptoms between panic disorder and posttraumatic stress disorder.
    Jensen CF; Peskind ER; Keller TW; McFall ME; Raskind MA
    Depress Anxiety; 1998; 7(3):122-5. PubMed ID: 9656092
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of aging on cholecystokinin-induced panic.
    Flint AJ; Koszycki D; Vaccarino FJ; Cadieux A; Boulenger JP; Bradwejn J
    Am J Psychiatry; 1998 Feb; 155(2):283-5. PubMed ID: 9464213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholecystokinin tetrapeptide on respiratory function in healthy volunteers.
    Bradwejn J; LeGrand JM; Koszycki D; Bates JH; Bourin M
    Am J Psychiatry; 1998 Feb; 155(2):280-2. PubMed ID: 9464212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia.
    Akiyoshi J; Isogawa K; Tsutsumi T; Kasturagi S; Kohno K; Furuta M; Yamamoto Y; Yamada K; Fujii I
    Biol Psychiatry; 1997 Jul; 42(2):151-4. PubMed ID: 9209734
    [No Abstract]   [Full Text] [Related]  

  • 12. Anxiety sensitivity and cholecystokinin tetrapeptide challenge.
    McNally RJ
    Am J Psychiatry; 1995 Feb; 152(2):300-1. PubMed ID: 7840376
    [No Abstract]   [Full Text] [Related]  

  • 13. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.
    Ströhle A; Kellner M; Holsboer F; Wiedemann K
    Am J Psychiatry; 2001 Sep; 158(9):1514-6. PubMed ID: 11532742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of panic disorder to posttraumatic stress disorder.
    Safadi G; Bradwejn J
    Arch Gen Psychiatry; 1995 Jan; 52(1):76-8. PubMed ID: 7811165
    [No Abstract]   [Full Text] [Related]  

  • 15. Trait dissociation affects the behavioral response to cholecystokinin tetrapeptide in healthy man.
    Kellner M; Yassouridis A; Hua Y; Wendrich M; Naber D; Wiedemann K
    Psychiatry Res; 2002 Aug; 111(1):93-6. PubMed ID: 12140124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A; Holsboer F; Rupprecht R
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
    Maron E; Tõru I; Mäemets K; Sepp S; Vasar V; Shlik J; Zharkovsky A
    J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte cholecystokinin concentrations in panic disorder.
    Brambilla F; Bellodi L; Perna G; Garberi A; Panerai A; Sacerdote P
    Am J Psychiatry; 1993 Jul; 150(7):1111-3. PubMed ID: 8317587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
    Bertoglio LJ; Zangrossi H
    Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K; Yassouridis A; Mass R; Tenge H; Kellner M; Jahn H; Wiedemann K; Wolf K
    J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.